Auriel Adonai Willette

Dr. Auriel Adonai Willette

Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
ASAshley Swanson
Ashley Swanson
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette

1 April 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
APAlexandra Plagman
Alexandra Plagman
SHSiobhan Hoscheidt
Siobhan Hoscheidt
KMKelsey E. McLimans
Kelsey E. McLimans
BKBrandon Klinedinst
Brandon Klinedinst
CPColleen Pappas
Colleen Pappas
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette

1 July 2021 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette
CPColleen Pappas
Colleen Pappas
NHNathan Hoth
Nathan Hoth
QWQian Wang
Qian Wang
BKBrandon Klinedinst
Brandon Klinedinst
RDRobert Dantzer
Robert Dantzer

1 July 2018 in Behavioural Brain Research
Verified
Journal Article
Closed access
ASAshley Swanson
Ashley Swanson
TWTovah Wolf
Tovah Wolf
ASAlli Sitzmann
Alli Sitzmann
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette

24 November 2020 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
BKBrandon S. Klinedinst
Brandon S. Klinedinst
SLScott T. Le
Scott T. Le
BLBrittany A. Larsen
Brittany A. Larsen
CPColleen Pappas
Colleen Pappas
NHNathan J. Hoth
Nathan J. Hoth
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette
Background: Fluid intelligence (FI) involves abstract problem-solving without prior knowledge. Greater age-related FI decline increases Alzheimer’s disease (AD) risk, and recent studies suggest that certain dietary regimens may influence rates of decline. However, it is uncertain how long-term food consumption affects FI among adults with or without familial history of AD (FH) or APOE4 (ɛ4). Objective: Observe how the total diet is associated with long-term cognition among mid- to late-life populations at-risk and not-at-risk for AD. Methods: Among 1,787 mid-to-late-aged adult UK Biobank participants, 10-year FI trajectories were modeled and regressed onto the total diet based on self-reported intake of 49 whole foods from a Food Frequency Questionnaire (FFQ). Results: Daily cheese intake strongly predicted better FIT scores over time (FH-: β= 0.207, p < 0.001; ɛ4–: β= 0.073, p = 0.008; ɛ4+: β= 0.162, p = 0.001). Alcohol of any type daily also appeared beneficial (ɛ4+: β= 0.101, p = 0.022) and red wine was sometimes additionally protective (FH+: β= 0.100, p = 0.014; ɛ4–: β= 0.59, p = 0.039). Consuming lamb weekly was associated with improved outcomes (FH-: β= 0.066, p = 0.008; ɛ4+: β= 0.097, p = 0.044). Among at risk groups, added salt correlated with decreased performance (FH+: β= –0.114, p = 0.004; ɛ4+: β= –0.121, p = 0.009). Conclusion: Modifying meal plans may help minimize cognitive decline. We observed that added salt may put at-risk individuals at greater risk, but did not observe similar interactions among FH- and AD- individuals. Observations further suggest in risk status-dependent manners that adding cheese and red wine to the diet daily, and lamb on a weekly basis, may also improve long-term cognitive outcomes.

1 December 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
KMKelsey E. McLimans
Kelsey E. McLimans
Auriel Adonai WilletteAuriel Adonai Willette
Auriel Adonai Willette
FIFor The Alzheimer’S Disease Neuroimaging Initiative
For The Alzheimer’S Disease Neuroimaging Initiative
Background: Obesity and insulin resistance are associated with neuropathology and cognitive decline in Alzheimer’s disease (AD). Objective: Ecto-nucleotide pyrophosphatase/phosphodiesterase 2, also called autotaxin, is produced by beige adipose tissue, regulates metabolism, and is higher in AD prefrontal cortex (PFC). Autotaxin may be a novel biomarker of dysmetabolism and AD. Methods: We studied Alzheimer’s Disease Neuroimaging Initiative participants who were cognitively normal (CN; n = 86) or had mild cognitive impairment (MCI; n = 135) or AD ( n = 66). Statistical analyses were conducted using SPSS software. Multinomial regression analyses tested if higher autotaxin was associated with higher relative risk for MCI or AD diagnosis, compared to the CN group. Linear mixed model analyses were used to regress autotaxin against MRI, FDG-PET, and cognitive outcomes. Spearman correlations were used to associate autotaxin and CSF biomarkers due to non-normality. FreeSurfer 4.3 derived mean cortical thickness in medial temporal lobe and prefrontal regions of interest. Results: Autotaxin levels were significantly higher in MCI and AD. Each point increase in log-based autotaxin corresponded to a 3.5 to 5 times higher likelihood of having MCI and AD, respectively. Higher autotaxin in AD predicted hypometabolism in the medial temporal lobe [R 2 = 0.343, p < 0.001] and PFC [R 2 = 0.294, p < 0.001], and worse performance on executive function and memory factors. Autotaxin was associated with less cortical thickness in PFC areas like orbitofrontal cortex [R 2 = 0.272, p < 0.001], as well as levels of total tau, p-tau181, and total tau/Aβ 1–42 . Conclusions: These results are comparable to previous reports using insulin resistance. CSF autotaxin may be a useful dysmetabolism biomarker for examining AD outcomes and risk.